4.2 Article

Exhaled Nitric Oxide in Pregnant Healthy and Asthmatic Women

期刊

JOURNAL OF ASTHMA
卷 46, 期 8, 页码 786-791

出版社

INFORMA HEALTHCARE
DOI: 10.3109/02770900903090004

关键词

nitric oxide; FENO; pregnancy; asthmatics; NIOX MINO; asthma control

资金

  1. Hungarian Scientific Research Foundation [OTKA 68808]

向作者/读者索取更多资源

Background. Measurement of fractioned exhaled nitric oxide (FENO) is useful for monitoring airway inflammation in asthma. Asthma is one of the most common diseases complicating pregnancy, and FENO may be helpful for monitoring asthma in pregnancy. However, some physiological alterations of FENO may be expected during healthy pregnancy due to vascular nitric oxide production. Until now no study assessed the level of FENO in asthmatic pregnant patients. Objective. We aimed to assess the possible use and reproducibility of FENO measurements in pregnant asthmatic women. We compared FENO concentrations between four groups of subjects: healthy nonpregnant and pregnant females and asthmatic nonpregnant and pregnant patients. We also investigated the relationship between FENO values and the level of asthma control in pregnant asthmatic patients. Methods. A total of 102 female subjects (35 healthy nonpregnant and 27 healthy pregnant females; 20 nonpregnant and 20 pregnant asthmatic women) were included in this cross-sectional study. Two FENO measurements were performed in each subject using an electrochemical sensor based device (NIOX MINO, Aerocrine, Solna, Sweden). Data are given as median with range. Results. The repeatability of FENO measurement was similar in pregnant and nonpregnant subjects. FENO levels did not differ significantly between healthy pregnant versus nonpregnant subjects (16.0 [8, 31] vs. 16.0 [9, 35] ppb). FENO levels were significantly increased in asthmatic women compared to healthy females (nonpregnant asthmatics: 38 [9, 54] ppb, p < 0.001 vs. healthy nonpregnant; pregnant asthmatic patients: 28 [10, 56] ppb; p < 0.05 vs. healthy pregnant). Conclusions. FENO level is not influenced by healthy pregnancy. In pregnant asthmatic patients FENO level is elevated compared to healthy pregnant subjects and correlates with the level of asthma control. Further studies are required to assess the use of FENO measurement to monitor asthma in this patient group.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据